Post-cardiac arrest myocardial dysfunction is a major cause of mortality in patients receiving successful cardiopulmonary resuscitation (CPR). Mild therapeutic hypothermia (MTH) is the recommended treatment after resuscitation from cardiac arrest (CA) and is known to exert neuroprotective effects and improve short-term survival. Yet its cytoprotective mechanisms are not fully understood. In this study, our aim was to determine the possible effect of MTH on vasoactive mediators belonging to the endothelin/nitric oxide axis in our porcine model of CA and CPR. Pigs underwent either untreated CA or CA with subsequent CPR. After state-of-the-art resuscitation, the animals were either left untreated, cooled between 32–34°C after ROSC or treated with a bolus injection of S-PBN (sodium 4-[(tert-butylimino) methyl]benzene-3-sulfonate N-oxide) until 180 min after ROSC, respectively. The expression of endothelin 1 (ET-1), endothelin converting enzyme 1 (ECE-1), and endothelin A and B receptors (ETAR and ETBR) transcripts were measured using quantitative real-time PCR while protein levels for the ETAR, ETBR and nitric oxide synthases (NOS) were assessed using immunohistochemistry and Western Blot. Our results indicated that the endothelin system was not upregulated at 30, 60 and 180 min after ROSC in untreated postcardiac arrest syndrome. Post-resuscitative 3 hour-long treatments either with MTH or S-PBN stimulated ET-1, ECE-1, ETAR and ETBR as well as neuronal NOS and endothelial NOS in left ventricular cardiomyocytes. Our data suggests that the endothelin and nitric oxide pathways are activated by MTH in the heart.
References
[1]
Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, et al. (2008) Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 118: 2452–2483.
[2]
Chalkias A, Xanthos T Pathophysiology and pathogenesis of post-resuscitation myocardial stunning. Heart Fail Rev 17: 117–128.
[3]
Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW, Kloeck WG, et al. (2003) Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation 108: 118–121.
[4]
Walters JH, Morley PT, Nolan JP (2011) The role of hypothermia in post-cardiac arrest patients with return of spontaneous circulation: a systematic review. Resuscitation 82: 508–516.
[5]
Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, et al. (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473–485.
[6]
Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, et al. (1993) Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526–538.
[7]
Kedzierski RM, Yanagisawa M (2001) Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41: 851–876.
[8]
Kolettis TM (2011) Endothelin-1 during myocardial ischaemia: a double-edged sword? Hypertens Res 34: 170–172.
[9]
Miclescu A, Basu S, Wiklund L (2007) Cardio-cerebral and metabolic effects of methylene blue in hypertonic sodium lactate during experimental cardiopulmonary resuscitation. Resuscitation 75: 88–97.
[10]
Forni M, Mazzola S, Ribeiro LA, Pirrone F, Zannoni A, et al. (2005) Expression of endothelin-1 system in a pig model of endotoxic shock. Regul Pept 131: 89–96.
[11]
Sharma HS, Cervos-Navarro J (1990) Brain oedema and cellular changes induced by acute heat stress in young rats. Acta Neurochir Suppl (Wien) 51: 383–386.
[12]
Miclescu A, Sharma HS, Martijn C, Wiklund L (2010) Methylene blue protects the cortical blood-brain barrier against ischemia/reperfusion-induced disruptions. Crit Care Med 38: 2199–2206.
[13]
Wiklund L, Sharma HS, Basu S (2005) Circulatory arrest as a model for studies of global ischemic injury and neuroprotection. Ann N Y Acad Sci 1053: 205–219.
[14]
Liu XL, Wiklund L, Nozari A, Rubertsson S, Basu S (2003) Differences in cerebral reperfusion and oxidative injury after cardiac arrest in pigs. Acta Anaesthesiol Scand 47: 958–967.
[15]
Hearse DJ, Tosaki A (1987) Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart. Circ Res 60: 375–383.
[16]
Tonnessen T, Giaid A, Saleh D, Naess PA, Yanagisawa M, et al. (1995) Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 76: 767–772.
[17]
Wainwright CL, McCabe C, Kane KA (2005) Endothelin and the ischaemic heart. Curr Vasc Pharmacol 3: 333–341.
[18]
Haynes WG, Hamer DW, Robertson CE, Webb DJ (1994) Plasma endothelin following cardiac arrest: differences between survivors and non-survivors. Resuscitation 27: 117–122.
[19]
Lindner KH, Haak T, Keller A, Bothner U, Lurie KG (1996) Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart 75: 145–150.
[20]
Meybohm P, Gruenewald M, Albrecht M, Zacharowski KD, Lucius R, et al. (2009) Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling. PLoS One 4: e7588.
[21]
Zhao XS, Pan W, Bekeredjian R, Shohet RV (2006) Endogenous endothelin-1 is required for cardiomyocyte survival in vivo. Circulation 114: 830–837.
[22]
Vrbjar N, Zollner S, Haseloff RF, Pissarek M, Blasig IE (1998) PBN spin trapping of free radicals in the reperfusion-injured heart. Limitations for pharmacological investigations. Mol Cell Biochem 186: 107–115.
[23]
Rapoport RM, Zuccarello M (2011) Endothelin(A)-endothelin(B) receptor cross-talk and endothelin receptor binding. J Pharm Pharmacol 63: 1373–1377.
[24]
Oikonomidis DL, Baltogiannis GG, Kolettis TM (2010) Do endothelin receptor antagonists have an antiarrhythmic potential during acute myocardial infarction? Evidence from experimental studies. J Interv Card Electrophysiol 28: 157–165.
[25]
Yamamoto S, Matsumoto N, Kanazawa M, Fujita M, Takaoka M, et al. (2005) Different contributions of endothelin-A and endothelin-B receptors in postischemic cardiac dysfunction and norepinephrine overflow in rat hearts. Circulation 111: 302–309.
[26]
Tawa M, Fukumoto T, Ohkita M, Yamashita N, Geddawy A, et al. (2011) Contribution of nitric oxide in big endothelin-1-induced cardioprotective effects on ischemia/reperfusion injury in rat hearts. J Cardiovasc Pharmacol 57: 575–578.
[27]
Massion PB, Balligand JL (2003) Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J Physiol 546: 63–75.
[28]
Beiser DG, Orbelyan GA, Inouye BT, Costakis JG, Hamann KJ, et al. (2010) Genetic deletion of NOS3 increases lethal cardiac dysfunction following mouse cardiac arrest. Resuscitation 82: 115–121.
[29]
Seddon M, Shah AM, Casadei B (2007) Cardiomyocytes as effectors of nitric oxide signalling. Cardiovasc Res 75: 315–326.
[30]
Burkard N, Williams T, Czolbe M, Blomer N, Panther F, et al. (2010) Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion. Circulation 122: 1588–1603.
[31]
Sasson C, Rogers MA, Dahl J, Kellermann AL (2010) Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 3: 63–81.
